UnknownNot Applicable

Microaspiration in ERCP

Egypt50 participantsStarted 2021-04-01

Plain-language summary

Endoscopic retrograde cholangiopancreatography (ERCP) is considered the gold standard in diagnosing and treating biliary and pancreatic diseases. Patients planned for ERCP often have additional comorbidities that make them high-risk candidates for general anesthesia so; the optimized choice of the anesthetic technique represents a real challenge. apparent aspiration is noticeable however microaspiration is hard to detect clinically. our study aims at determining whether general anesthesia with endotracheal intubation or deep sedation is safer in ERCP patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ASA 1-3.
✓. Age above 18 years old.
✓. Preoperative pulmonary stability criteria (defined as a respiratory rate 12-24 breaths per minute, SpO2 ≥ 94% on room air) -

Exclusion criteria

✕. Age \< 18 years.
✕. Morbid obesity BMI ≥ 40 Kg/ m2.
✕. Pregnancy.
✕. Fasting ≤ 6 hours for solid food and ≤ 2 hours for clear liquids. 4
✕. A pre-existing lung condition in patients requiring supplemental oxygen, inhalational bronchodilator, or systemic bronchodilator or steroid.
✕. Patients in the intensive care unit and/or requiring mechanical ventilation prior to the procedure.
✕. Previously intubated patients during the same hospitalization.
✕. Tracheostomized patients.

What they're measuring

POPA

Timeframe: 24 hours postoperatively

Trial details

NCT IDNCT04831489

SponsorTheodor Bilharz Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12

View on ClinicalTrials.gov More Pulmonary Microaspiration trials